Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
Each line starts at 100 so growth is directly comparable
| Metric | CHGCY | ALAB |
|---|---|---|
| Price | $19.31 | $362.34 |
| Change today | ▲ 1.21% | ▲ 3.43% |
| Market cap | $62.80B | $62.86B |
| Return, 3 months | -17.8% | -5.4% |
| Return, year to date | -26.5% | +117.8% |
| Return, 1 year | -22.5% | +64.1% |
| P/E (TTM) | 20.8 | 178.5 |
| P/B | 4.9 | 36.4 |
| P/E percentile vs own 5y | – | 72nd |
| Dividend yield | 3.45% | – |
| Revenue growth (YoY, latest qtr) | – | +104.5% |
| Net profit growth (YoY) | – | +198.9% |
| Gross margin | – | 75.1% |
| Operating margin | – | 22.8% |
| Net margin | – | 30.7% |
| Return on equity | – | 25.8% |
| Analyst target vs. price | – | +15.0% |
| Analyst buy share | – | 75% |
| RSI (14) | 33 | 62 |
| 30-day volatility | 27.8% | 82.6% |
| Max drawdown, 1 year | -43.2% | -56.4% |
| Trend read | Strong downtrend | Strong uptrend |
| Analyst consensus | – | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
